Nursing Knowledge, Practice Patterns, and Learning Preferences Regarding Chemotherapy-Induced
Peripheral Neuropathy Page 1 Oncology Nursing Forum • Vol. 41, No. 6, November 2014 669 …

Abstract Purpose/Objectives: To explore oncology nurses' practice behaviors and
knowledge of chemotherapy-induced peripheral neuropathy (CIPN) in the assessment of …

Peripheral neuropathies are a common side effect of certain types of chemotherapy drugs,
including taxanes, platinum-based drugs, vinca alkaloids, and thalidomide. Neuropathies …

The focus of this study was to assess the feasibility and clinical implementation of a
standardized assessment for chemotherapy-induced peripheral neuropathy (CIPN) by …

Peripheral neuropathy is a condition that can be caused or exacerbated by the
administration of certain chemotherapeutic agents. The effects of chemotherapy-induced …

Chemotherapy-induced peripheral neuropathy (CIPN) continues to be a significant,
debilitating symptom resulting from the administration of neurotoxic chemotherapy for the …

Objective To improve patient experience of chemotherapy‐induced peripheral neuropathy
(CIPN), it is crucial to identify how patients develop their understanding and perception of …

Oncology nurses play a critical role in assessment and management of chemotherapy-
induced peripheral neuropathy. Baseline and ongoing evaluation of physical function is a …

OBJECTIVES: To discuss the challenges associated with treating pain and altered
sensations due to chemotherapy-induced peripheral neuropathy (CIPN). DATA SOURCES …

The aim of this review was to systematically identify, appraise and synthesise qualitative
research evidence on the experience of adult cancer patients living with chemotherapy …